SEC 13F Intelligence

Berylson Capital Partners, LLC / ADPT

Berylson Capital Partners, LLC’s Adaptive Biotechnologies Cor Position

Does Berylson Capital Partners, LLC own Adaptive Biotechnologies Cor (ADPT)? Not currently — the last reported position was 228.0K shares worth $2M in Q2 2023; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$2M
Q2 2023
Shares
228.0K
% of Portfolio
+4.33%
Quarters Held
8
position exited

Position History ADPT

Reported value by quarter
Q1 ’21: $13MQ1 ’21Q2 ’21: $10MQ2 ’21Q3 ’21: $2MQ3 ’21Q2 ’22: $2MQ2 ’22Q3 ’22: $2MQ3 ’22Q4 ’22: $2MQ4 ’22Q1 ’23: $2MQ1 ’23Q2 ’23: $2MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2023228.0K$2M+4.33%
Q1 2023270.0K$2M+6.00%
Q4 2022289.7K$2M+6.45%
Q3 2022289.7K$2M+3.41%
Q2 2022189.7K$2M+4.15%
Q3 202161.0K$2M+0.96%
Q2 2021246.2K$10M+2.23%
Q1 2021316.0K$13M+3.10%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Berylson Capital Partners, LLC’s full portfolio or all institutional holders of ADPT.